Biotechnology CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry October 7, 2020
Biotechnology BioMarin, Pioneer in Rare Disease Treatments for Phenylketonuria (PKU), Receives FDA Approval of Label Expansion to Allow Maximum Dose of 60 mg for Palynziq® (pegvaliase-pqpz) Injection for Treatment of Adults with PKU October 7, 2020
Biotechnology Denali Therapeutics Announces Closing of Collaboration and Share Purchase Agreements with Biogen October 7, 2020
Health Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business October 7, 2020
Biotechnology BIOMARIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. – BMRN October 6, 2020
Biotechnology Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares October 6, 2020